These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 31591939)
1. DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1. Wu Q; Ma J; Meng W; Hui P Cancer Biol Ther; 2020; 21(1):17-25. PubMed ID: 31591939 [TBL] [Abstract][Full Text] [Related]
3. LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer. Yang Z; Dong X; Pu M; Yang H; Chang W; Ji F; Liu T; Wei C; Zhang X; Qiu X Gastric Cancer; 2020 May; 23(3):449-463. PubMed ID: 31673844 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of long noncoding RNA DLX6-AS1 inhibits cell proliferation and invasion of cervical cancer cells by downregulating FUS. Tian Y; Wang YR; Jia SH Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7307-7313. PubMed ID: 31539117 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p. Li D; Tang X; Li M; Zheng Y J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988 [TBL] [Abstract][Full Text] [Related]
6. Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis. Jia P; Wei E; Liu H; Wu T; Wang H IUBMB Life; 2020 Dec; 72(12):2627-2636. PubMed ID: 33031637 [TBL] [Abstract][Full Text] [Related]
7. DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290. Qian Y; Song W; Wu X; Hou G; Wang H; Hang X; Xia T Dig Dis Sci; 2021 Feb; 66(2):460-473. PubMed ID: 32239379 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Huang Y; Ni R; Wang J; Liu Y Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440 [TBL] [Abstract][Full Text] [Related]
9. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway. Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA DLX6-AS1 mediates proliferation, invasion and apoptosis of endometrial cancer cells by recruiting p300/E2F1 in DLX6 promoter region. Zhao H; Xu Q J Cell Mol Med; 2020 Nov; 24(21):12572-12584. PubMed ID: 32951317 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription. Lei JJ; Li HQ; Mo ZH; Liu KJ; Zhu LJ; Li CY; Chen WL; Zhang L FASEB J; 2019 Jun; 33(6):7037-7048. PubMed ID: 30870006 [TBL] [Abstract][Full Text] [Related]
12. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p. Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911 [TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of lncRNA TP73-AS1 predicts unfavorable prognosis for gastric cancer and promotes cell migration and invasion by induction of EMT. Zhang W; Zhai Y; Wang W; Cao M; Ma C Gene; 2018 Dec; 678():377-383. PubMed ID: 30118890 [TBL] [Abstract][Full Text] [Related]
14. lncRNA HOXC-AS1 promotes gastric cancer via binding eIF4AIII by activating Wnt/β-catenin signaling. Zhou C; An N; Cao C; Wang G J Gene Med; 2020 Sep; 22(9):e3202. PubMed ID: 32307743 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway. Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011 [TBL] [Abstract][Full Text] [Related]
16. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells. Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression. Wang X; Ren M; Li Y; Hu J; Lu G; Ma W; Guo D; Lu X; He S J Cell Biochem; 2019 Apr; 120(4):5704-5712. PubMed ID: 30324628 [TBL] [Abstract][Full Text] [Related]
18. LncRNA MYLK-AS1 acts as an oncogene by epigenetically silencing large tumor suppressor 2 (LATS2) in gastric cancer. Luo J; Xiang H Bioengineered; 2021 Dec; 12(1):3101-3112. PubMed ID: 34181498 [TBL] [Abstract][Full Text] [Related]
19. HOXC-AS1-MYC regulatory loop contributes to the growth and metastasis in gastric cancer. Dong Y; Li X; Lin Z; Zou W; Liu Y; Qian H; Jia J J Exp Clin Cancer Res; 2019 Dec; 38(1):502. PubMed ID: 31870402 [TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA Xie F; Xie G; Sun Q Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747 [No Abstract] [Full Text] [Related] [Next] [New Search]